JP2009544740A5 - - Google Patents

Download PDF

Info

Publication number
JP2009544740A5
JP2009544740A5 JP2009522019A JP2009522019A JP2009544740A5 JP 2009544740 A5 JP2009544740 A5 JP 2009544740A5 JP 2009522019 A JP2009522019 A JP 2009522019A JP 2009522019 A JP2009522019 A JP 2009522019A JP 2009544740 A5 JP2009544740 A5 JP 2009544740A5
Authority
JP
Japan
Prior art keywords
administration
alkyl
composition
composition according
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009522019A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544740A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/074603 external-priority patent/WO2008014457A1/en
Publication of JP2009544740A publication Critical patent/JP2009544740A/ja
Publication of JP2009544740A5 publication Critical patent/JP2009544740A5/ja
Pending legal-status Critical Current

Links

JP2009522019A 2006-07-28 2007-07-27 網膜外層の障害を治療するためのモノアミンオキシダーゼ阻害剤 Pending JP2009544740A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82073506P 2006-07-28 2006-07-28
PCT/US2007/074603 WO2008014457A1 (en) 2006-07-28 2007-07-27 Monoamine oxidase inhibitors useful for treating disorders of the outer retina

Publications (2)

Publication Number Publication Date
JP2009544740A JP2009544740A (ja) 2009-12-17
JP2009544740A5 true JP2009544740A5 (cg-RX-API-DMAC7.html) 2011-08-04

Family

ID=38743901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009522019A Pending JP2009544740A (ja) 2006-07-28 2007-07-27 網膜外層の障害を治療するためのモノアミンオキシダーゼ阻害剤

Country Status (11)

Country Link
US (1) US20110160308A1 (cg-RX-API-DMAC7.html)
EP (1) EP2046451A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009544740A (cg-RX-API-DMAC7.html)
KR (1) KR20090034365A (cg-RX-API-DMAC7.html)
CN (1) CN101495185A (cg-RX-API-DMAC7.html)
AU (1) AU2007278837A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0714985A2 (cg-RX-API-DMAC7.html)
CA (1) CA2658246A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009000792A (cg-RX-API-DMAC7.html)
WO (1) WO2008014457A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200900234B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109251155A (zh) * 2017-07-14 2019-01-22 广东东阳光药业有限公司 α-氨基酰胺衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
EP0808160A1 (en) * 1995-02-10 1997-11-26 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives

Similar Documents

Publication Publication Date Title
JP2007535552A5 (cg-RX-API-DMAC7.html)
JP2017503835A (ja) 眼球疾患治療のための組成物及び方法
JP2008505173A (ja) 痛みおよび他のα2アドレナリン作動性仲介状態を処置するための方法および組成物
JP2008538215A5 (cg-RX-API-DMAC7.html)
JP2012531405A (ja) 薬物嗜癖の治療および嗜癖関連行動を改善するための組成物
JP2006512318A5 (cg-RX-API-DMAC7.html)
JPWO2010010702A1 (ja) 軸性近視の予防または治療剤
JP2021503449A (ja) 眼障害の処置のための組成物及び方法
JP2023506838A5 (cg-RX-API-DMAC7.html)
US20100137342A1 (en) Methods for treating vascular disruption disorders
AU2020262932A1 (en) Intracanalicular hydrogel inserts for the delivery of anesthetics
JP2009196973A (ja) キナゾリノン誘導体又はキノキサリン誘導体を有効成分として含有する後眼部疾患の予防又は治療剤
JP2007527417A (ja) 白内障、黄斑変性および他の眼疾患の改善
RU2006124557A (ru) Композиции и способы введения средств, связывающих тубулин, для лечения глазных заболеваний
JPWO2002000260A1 (ja) 視神経疾患等治療剤
JP2013501794A (ja) 目の疾患を治療するためのイソチオゾール
JP2004506010A5 (cg-RX-API-DMAC7.html)
WO2010117077A1 (ja) シロリムス誘導体を有効成分として含有する網脈絡膜疾患の治療剤
JPH07215872A (ja) ベンゾ[g]キノリン類の新規使用
WO2004060373A1 (ja) 滲出型加齢黄斑変性治療剤
CN103826631A (zh) 用于治疗视网膜疾病的包含4-溴-n-(咪唑烷-2-亚基)-1h-苯并咪唑-5-胺的药物组合物
WO2022090379A1 (en) No-pde5 inhibitor for use in treating dry age-related macular degeneration, geographic atrophy and glaucoma-associated neurodegeneration
CN118159267A (zh) 用于治疗神经退行性眼病的普利多匹定及其类似物
WO2006123675A1 (ja) アミジノ誘導体を有効成分として含む神経細胞の保護剤
WO2006123674A1 (ja) アミン誘導体を有効成分として含む血管新生阻害剤